TY - JOUR
T1 - Natural history of Tay-Sachs disease in sheep
AU - Story, Brett
AU - Taghian, Toloo
AU - Gallagher, Jillian
AU - Koehler, Jey
AU - Taylor, Amanda
AU - Randle, Ashley
AU - Nielsen, Kayly
AU - Gross, Amanda
AU - Maguire, Annie
AU - Carl, Sara
AU - Johnson, Siauna
AU - Fernau, Deborah
AU - Diffie, Elise
AU - Cuddon, Paul
AU - Corado, Carly
AU - Chandra, Sundeep
AU - Sena-Esteves, Miguel
AU - Kolodny, Edwin
AU - Jiang, Xuntian
AU - Martin, Douglas
AU - Gray-Edwards, Heather
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.
AB - Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.
KW - Large animal model
KW - Neurodegeneration
KW - Sheep
KW - Tay-Sachs
KW - Translational
KW - Veterinary
UR - https://www.scopus.com/pages/publications/85113801313
U2 - 10.1016/j.ymgme.2021.08.009
DO - 10.1016/j.ymgme.2021.08.009
M3 - Article
C2 - 34456134
AN - SCOPUS:85113801313
SN - 1096-7192
VL - 134
SP - 164
EP - 174
JO - Molecular genetics and metabolism
JF - Molecular genetics and metabolism
IS - 1-2
ER -